Differential toxicity of gold-doxorubicin in cancer cells vs. cardiomyocytes as measured by real-time growth assays and fluorescence lifetime imaging microscopy (FLIM)

Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index

(2015) Esther Tahover et al.   ANTI-CANCER DRUGS

Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress

(2015) Inês Marques-Aleixo et al.   MITOCHONDRION

Intratumoral gold-doxorubicin is effective in treating melanoma in mice

(2015) Xuan Zhang et al.   Nanomedicine-Nanotechnology Biology and Medicine

Nuclear uptake of ultrasmall gold-doxorubicin conjugates imaged by fluorescence lifetime imaging microscopy (FLIM) and electron microscopy

(2015) Xuan Zhang et al.   Nanoscale

Chronic heart damage following doxorubicin treatment is alleviated by lovastatin

(2015) Christian Henninger et al.   PHARMACOLOGICAL RESEARCH

An overview of doxorubicin formulations in cancer therapy

(2015) Sangeeta Rivankar   Journal of Cancer Research and Therapeutics

The flavonoid quercetin: Possible solution for anthracycline-induced cardiotoxicity and multidrug resistance

(2014) Jan Czepas et al.   BIOMEDICINE & PHARMACOTHERAPY

Induction of apoptosis by doxorubicin–transferrin conjugate compared to free doxorubicin in the human leukemia cell lines

(2014) Marzena Szwed et al.   CHEMICO-BIOLOGICAL INTERACTIONS

An update on the risk prediction and prevention of anticancer therapy-induced cardiotoxicity

(2014) Manali Bhave et al.   CURRENT OPINION IN ONCOLOGY

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nanoparticles Based on Star Polymers as Theranostic Vectors: Endosomal-Triggered Drug Release Combined with MRI Sensitivity

(2014) Yang Li et al.   Advanced Healthcare Materials

Using Fluorescence Lifetime Imaging Microscopy to Monitor Theranostic Nanoparticle Uptake and Intracellular Doxorubicin Release

(2013) Johan S. Basuki et al.   ACS Nano

Mechanistic Modeling Identifies Drug-Uptake History as Predictor of Tumor Drug Resistance and Nano-Carrier-Mediated Response

(2013) Jennifer Pascal et al.   ACS Nano

Functional Iron Oxide Magnetic Nanoparticles with Hyperthermia-Induced Drug Release Ability by Using a Combination of Orthogonal Click Reactions

(2013) Thuy T. T. N'Guyen et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Study of Intracellular Delivery of Doxorubicin from Poly(lactide-co-glycolide) Nanoparticles by Means of Fluorescence Lifetime Imaging and Confocal Raman Microscopy

(2013) Gabriela Romero et al.   MACROMOLECULAR BIOSCIENCE

Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review

(2013) Ping Ma et al.   Nano Today

The intranuclear release of a potential anticancer drug from small nanoparticles that are derived from intracellular dissociation of large nanoparticles

(2012) Yanbin Fan et al.   BIOMATERIALS

Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells

(2011) Feng Wang et al.   ACS Nano

Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells

(2011) Jingwei Zhang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pharmacodynamic Modeling ofIn VitroActivity of Marbofloxacin againstEscherichia coliStrains

(2010) M. Andraud et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ultrasmall Gold−Doxorubicin Conjugates Rapidly Kill Apoptosis-Resistant Cancer Cells

(2010) Xuan Zhang et al.   BIOCONJUGATE CHEMISTRY

Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma

(2009) Padmaparna Chaudhuri et al.   NANOTECHNOLOGY